Regadenoson Injection Articles
CV board rejects Astellas bid for second time
2 March 2009
CV's 3rd-qtr 2008 loss narrows 26% to $25.4M
17 November 2008
US FDA set for even fewer approvals in 2008
1 September 2008
Japan stock market week to June 30, 2008
7 July 2008
Lexiscan launch earns CV $10M milestone
30 June 2008
Japan stock market week to Aril 21, 2008
28 April 2008
FDA approval for CV and Astellas' Lexiscan
28 April 2008
Showing 1-7 of 7 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
